An AI-enabled drug discovery company dramatically accelerating the development of best-in-class drugs. Entos has built an AI-powered suite of tools called “OrbNet” for modeling the chemical properties of drug candidates 1000-fold faster than industry standard techniques. By integrating OrbNet with their cutting edge NanoSAR automated synthesis and screening platform, Entos can more efficiently explore the physiochemical properties and potency of new chemical entities during hit-to-lead and lead optimization, resulting in a faster path to developing safer and more efficacious drugs.

No items found.